pros and cons of microdosing tirzepatide GLP-1s: Does It Work? Risks Benefits Microdosing GLP-1 Agonists: A New

The clinical applications of IGF-1 LR3 span across various growth deficiencies and conditions requiring anabolic support, including hormone deficiencies leading to short stature, Turner Syndrome, muscle-wasting diseases, and conditions associated with pituitary tumors

Complexity of Effects: The broad mechanism of action might lead to unexpected side effects or interactions that are not yet fully understood

Clinical evidence does not favor morning over evening injection timing

[42] Agarwal A, Sengupta P, Durairajanayagam D

doi:10.1681/ASN.0000000512 15

These longer cycles require more careful monitoring and may benefit from slight dose reductions in weeks 13-16 to maintain receptor sensitivity